Tricky… [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2020-01-30 19:18 (724 d 17:08 ago) – Posting: # 21112
Views: 17,055

Salam Osama,

» » […] with fixed (!) limits of 75.00–133.33% if CVwR <30%.
»
» I think there is a mistake here, you are right according to the fixed limit of 75-133% in the GCC Guidelines in the case of HVD (HVDP) which is absolutely not correct and cause a lot of problems in the evaluation of such drug formulation's types, BUT widen to this range is not in the case of ABE and not at all if CVwR <30% .

Of course, of course! Sorry, it was a stupid typing error. :angry:

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,849 posts in 4,572 threads, 1,555 registered users;
online 11 (1 registered, 10 guests [including 3 identified bots]).
Forum time: Monday 12:27 CET (Europe/Vienna)

Do, or do not.
There is no ‘try’.    Yoda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5